Response to Comments on Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with Donepezil

This publication has 11 references indexed in Scilit:

• Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
• Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease who Failed to Benefit from Treatment with Donepezil
  Current Medical Research and Opinion, 2002
• Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina
  Mechanisms of Ageing and Development, 2001
• A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
  Neurology, 2001
• Open-Label, Multicenter, Phase 3 Extension Study of the Safety and Efficacy of Donepezil in Patients With Alzheimer Disease
  Archives of Neurology, 2001
• Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
  Neuroscience Letters, 2001
• The Sin of Omission: A Systematic Review of Antithrombotic Therapy to Prevent Stroke in Atrial Fibrillation
  Journal of the American Geriatrics Society, 2001
• Four Instrumental Activities of Daily Living Score as a Predictor of One-year Incident Dementia
  Age and Ageing, 1993
• Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease
  Published by Elsevier ,1993
• Instrumental Activities of Daily Living as a Screening Tool for Cognitive Impairment and Dementia in Elderly Community Dwellers
  Journal of the American Geriatrics Society, 1992